Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 3,500,000 $ 1,240 $ 31,864,479 $ (30,353,768) $ 5,011,951
Beginning balance, shares at Dec. 31, 2020 350,000 12,402,157      
Stock-based compensation expense 656,032 656,032
Net loss (1,727,144) (1,727,144)
Proceeds from sale of common stock in direct equity offering, net of offering costs $ 113 3,689,648 3,689,761
Proceeds from sale of common stock in direct equity offering, net of offering costs, shares   1,133,102      
Exercise of warrants $ 1 17,099 17,100
Exercise of warrants, shares   3,000      
Ending balance, value at Mar. 31, 2021 $ 3,500,000 $ 1,354 36,227,258 (32,080,912) 7,647,700
Ending balance, shares at Mar. 31, 2021 350,000 13,538,259      
Beginning balance, value at Dec. 31, 2021 $ 3,500,000 $ 1,374 38,371,128 (37,082,164) 4,790,338
Beginning balance, shares at Dec. 31, 2021 350,000 13,746,593      
Stock-based compensation expense 339,672 339,672
Net loss (1,656,918) (1,656,918)
Ending balance, value at Mar. 31, 2022 $ 3,500,000 $ 1,374 $ 38,710,800 $ (38,739,082) $ 3,473,092
Ending balance, shares at Mar. 31, 2022 350,000 13,746,593